医療研究のレビュー：2007年

Abstract

INTRODUCTION

Advances in healthcare technology have extended the lifetimes and improved the quality of life of millions of people. Global markets for healthcare technology will continue to grow very strongly for the foreseeable future; as other technology markets mature and experience slower growth - or no growth at all - technologies used in healthcare continue to expand at robust rates.

This review includes highlights of reports published by BCC Research on the following healthcare technology markets:

• Biocompatible Materials for the Human Body
• Advanced Orthopedic Technologies, Implants and Regenerative Products
• Microelectronic Medical Implants: Products, Technology & Opportunities
• The Global Market for Pain Management Drugs and Devices
• Medical Imaging: Equipment and Related Products
• The Home Medical Equipment Market.

We hope you find this Research Review valuable, and we look forward to another year of serving our customers' technology market research needs.

Table of Contents

• 2007 Healthcare Research Review
• Chapter 1 - BIOCOMPATIBLE MATERIALS FOR THE HUMAN BODY
  • BIOCOMPATIBLE MATERIALS FOR THE HUMAN BODY
  • INTRODUCTION
    • STUDY GOAL AND OBJECTIVES
    • REASONS FOR DOING THE STUDY
    • INTENDED AUDIENCE
    • SCOPE OF REPORT
    • INFORMATION SOURCES
    • ANALYST' S CREDENTIALS
    • RELATED BCC REPORTS
    • BCC ONLINE SERVICES
    • DISCLAIMER
  • SUMMARY
  • Summary Table: U.S. MARKET FORECAST FOR BIOCOMPATIBLE MATERIALS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
  • Summary Figure: U.S. MARKET FOR BIOCOMPATIBLE MATERIALS, BY SEGMENT 2004-2012 ($ MILLIONS)
  • OVERVIEW
    • INTRODUCTION TO BIOCOMPATIBLE MATERIALS
    • TYPES OF MATERIALS
      • CERAMICS
        • Ceramics (Continued)
  • Table 1 COMMON BIOCOMPATIBLE CERAMICS
    • METALS
      • Titanium
      • Gold
      • Platinum
  • Table 2 COMMON BIOCOMPATIBLE METALS
    • POLYMERS
      • PLA and PGA
      • PTFE
  • Table 3 COMMON BIOCOMPATIBLE POLYMERES
    • NATURAL MATERIALS
      • Collagen
      • Chitosan
      • Alginate
  • Table 4 COMMON BIOCOMPATIBLE NATURAL MATERIALS
    • TECHNOLOGY
      • ADVANCES IN BIOACTIVE MATERIALS
        • GROWTH FACTORS
        • DRUG-ELUTING SURFACES
        • HYDROGELS
          • Hydrogels for Growth Factor Delivery
          • Mechanoresponsive Hydrogels
          • Poly(HEMA)
        • DEGRADABLE OR BIORESORBABLE MATERIALS
          • Chitosan
          • Polyethylene Oxide
          • Ethylene-vinyl Acetate
      • THE CHALLENGES OF BIOCOMPATIBILITY
        • BLOOD COMPATIBILITY AND PROTEIN ADSORPTION
          • Albumin
          • Immunoglobulins
          • Fibrinogen
        • CALCIFICATION
        • INFECTION AND BIOFILMS
        • HOST IMMUNE RESPONSE
          • Wound Healing and Inflammation
          • Foreign Body Immune Reaction and Rejection
          • Complement Immune Response
      • RECENT ADVANCES IN ENABLING TECHNOLOGIES
        • BIOMIMETICS
        • NANOTECHNOLOGY
        • TISSUE ENGINEERING
        • STEM CELLS
        • BIOREACTOR TECHNOLOGY
      • IMPLANTABLE MEDICAL DEVICES
  • Table 11 U.S. MARKET FORECAST FOR IMPLANTABLE MEDICAL DEVICES BY SEGMENT, THROUGH 2012 ($ MILLIONS)
  • Figure 5 U.S. MARKET FOR IMPLANTABLE MEDICAL DEVICES, BY SEGMENT 2004-2012 ($ MILLIONS)
    • SURFACE COATINGS
  • Table 13 U.S. MARKET FORECAST FOR BIOCOMPATIBLE SURFACE COATINGS BY SEGMENT, THROUGH 2012 ($ MILLIONS)
  • Figure 7 U.S. MARKET FOR BIOCOMPATIBLE SURFACE COATINGS BY SEGMENT, 2004-2012 ($ MILLIONS)
    • SURFACE COATINGS (CONTINUED)
• Chapter 2 - ADVANCED ORTHOPEDIC TECHNOLOGIES, IMPLANTS AND REGENERATIVE PRODUCTS
  • ADVANCED ORTHOPEDIC TECHNOLOGIES, IMPLANTS AND REGENERATIVE PRODUCTS
    • INTRODUCTION
    • STUDY GOALS AND OBJECTIVES
    • REASONS FOR DOING THE STUDY
    • SCOPE OF THE REPORT
    • METHODOLOGY
    • RELATED BCC STUDIES
    • ANALYST CREDENTIALS
  • SUMMARY
  • Summary Table: ADVANCED ORTHOPEDIC TECHNOLOGY, IMPLANTS, AND REGENERATIVE PRODUCTS, THROUGH 2012 ($ MILLIONS)
  • Summary Figure: ADVANCED ORTHOPEDIC TECHNOLOGY, IMPLANTS AND REGENERATIVE PRODUCTS, 2005-2012 ($ MILLIONS)
  • MARKETS BY WORLD REGION
  • Table 31 WORLDWIDE DISTRIBUTION OF REVENUES FROM CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS BY REGION, 2006 (%)
  • Figure 23 WORLDWIDE DISTRIBUTION OF REVENUES FROM CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS BY REGION, 2006 (%)
    • LEADING SUPPLIERS AND PARTICIPANTS
  • Table 32 SUMMARY OF CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 ($ MILLIONS)
  • Figure 24 SUMMARY OF CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 (%)
  • Table 38 GLOBAL JOINT REPLACEMENT, IMPLANT AND REGENERATIVE PRODUCT MARKET FORECASTS, THROUGH 2012 ($ MILLIONS)
  • Figure 25 GLOBAL JOINT REPLACEMENT, IMPLANT AND REGENERATIVE PRODUCT MARKET FORECASTS, 2005-2012 ($ MILLIONS)
    • EMERGING TECHNOLOGY AREAS
      • NANOTECHNOLOGY AND MICROPROCESSORS
      • DIGITAL X-RAYS
      • BONE DENSITY IMPROVEMENTS
      • HIGH-RESOLUTION CARTILAGE IMAGING
      • STEM CELLS
        • Government Limitations
        • Embryonic Stem Cells
        • Adult Stem Cells
        • New Stem Cell Findings
        • Bone Technology and Stem Cells
      • SYNTHETIC BONE GRAFTING TECHNOLOGY
      • BONE MODELING FOR OSTEOPOROTIC SPINAL FRACTURE TESTING
      • ADVANCED MECHANICAL IMPLANT CREATION
    • CURRENT TECHNOLOGY USES
      • BONE GROWTH STIMULATORS
      • TENS UNITS
      • LED THERAPY
      • LIGHT-EMITTING DIODES WITH INFRARED LASERS
      • THERMAL IMAGING
    • BONE REPAIR AND REGENERATIVE PRODUCTS
      • BONE GRAFTS
  • Table 21 BONE GRAFT PRODUCTS AND MATERIALS
    • PROCEDURES USING BONE GRAFTS
• Chapter 3 - MICROELECTRONIC MEDICAL IMPLANTS: PRODUCTS, TECHNOLOGIES & OPPORTUNITIES
  • MICROELECTRONIC MEDICAL IMPLANTS: PRODUCTS, TECHNOLOGIES & OPPORTUNITIES
  • INTRODUCTION
    • MICROELECTRONIC MEDICAL IMPLANTS
    • STUDY BACKGROUND
    • STUDY GOALS AND OBJECTIVES
    • INTENDED AUDIENCE
    • SCOPE OF THE STUDY
    • METHODOLOGY AND INFORMATION SOURCES
    • ANALYST CREDENTIALS
    • OTHER RELEVANT BCC REPORTS
  • EXECUTIVE SUMMARY
  • Summary Table: GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS BY APPLICATION, THROUGH 2012 ($ BILLIONS)
  • Summary Figure: GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS BY APPLICATION, 2006-2012 ($ BILLIONS)
    • EXECUTIVE SUMMARY (CONTINUED)
  • OVERVIEW OF MICROELECTRONIC IMPLANTS
    • GENERAL DESCRIPTION
      • DEFINITION
      • HISTORY OF MICROELECTRONIC IMPLANTS
        • Early Origins
        • Early Pacemakers
        • Advances in Pacemaker Technology
        • First Implantable Defibrillator
        • Neurostimulators
        • First Implantable Drug Pump
        • Cardiac Assist/Replacement Devices
        • Ear Implants
        • Eye Implants
    • TECHNOLOGIES
      • MINIATURIZATION
      • MATERIALS
      • SENSORS
      • POWER SUPPLIES
      • RF TECHNOLOGY
    • APPLICATIONS
      • CARDIOVASCULAR DISEASE
  • Table 1 HOSPITALIZATIONS, PHYSICIAN OFFICE VISITS, AND DEATHS DUE TO HEART DISEASE IN THE U.S., 2001-2002*
    • Brachycardia
    • Hypertrophic Cardiomyopathy
    • Tachyarrhythmia
    • Syncope
    • Heart Failure
  • NEUROLOGICAL DISEASES/CONDITIONS
    • Chronic Pain
    • Spinal Cord Injuries
    • Parkinson' s Disease
    • Epilepsy
    • Depression
    • Muscle Spasticity
    • Urge Incontinence
    • Other Conditions
      • Alzheimer' s Disease
    • BONE DAMAGE
    • DIABETES
    • CANCER
  • Figure 1 TRENDS IN U.S. CANCER DEATHS, 1998-2006
    • IMPAIRED HEARING
    • BLINDNESS
      • BLINDNESS (continued)
    • GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS
      • SUMMARY
  • Figure 12 TRENDS IN GLOBAL MARKET FOR MICROELECTRONIC MEDICAL IMPLANTS, 2006-2012 ($ BILLIONS)
    • DETAILED MARKET ESTIMATES AND PROJECTIONS, 2002-2009
  • Table 12 GLOBAL MARKET FORECAST FOR MICROELECTRONIC MEDICAL IMPLANTS BY TYPE OF IMPLANT, THROUGH 2012 ($ MILLIONS)
  • Figure 13 TRENDS IN MICROELECTRONIC MEDICAL IMPLANT APPLICATION MARKET SHARES, 2006 AND 2012 (PERCENT OF TOTAL IMPLANT SALES)
  • Figure 13 (CONTINUED)
• Chapter 4 - THE GLOBAL MARKET FOR PAIN MANAGEMENT DRUGS AND DEVICES
  • THE GLOBAL MARKET FOR PAIN MANAGEMENT DRUGS AND DEVICES
  • INTRODUCTION
    • STUDY GOALS AND OBJECTIVES
    • REASONS FOR DOING THIS STUDY
    • CONTRIBUTIONS TO THE STUDY AND FOR WHOM
    • SCOPE AND FORMAT
    • METHODOLOGY
    • INFORMATION SOURCES
    • ABOUT THE AUTHOR
    • RELATED BCC REPORTS
  • SUMMARY
    • Summary Table: GLOBAL PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
    • Summary Figure: SHARE OF GLOBAL PAIN-MANAGEMENT MARKET, BY SEGMENT 2007 AND 2012 (%)
      • PAIN-MANAGEMENT MARKET ANALYSIS
  • Table 10 HEALTHCARE DEMOGRAPHICS OF OECD COUNTRIES
  • Table 10 (CONTINUED)
    • METHODS THAT PROVIDE PAIN RELIEF
  • Figure 7 PAIN MANAGEMENT METHODS
    • PAIN-MANAGEMENT MARKET
  • Table 11 GLOBAL PAIN-MANAGEMENT MARKET, THROUGH 2012 ($ BILLIONS)
  • Figure 8 GLOBAL PAIN-MANAGEMENT MARKET, 2005-2012
    • PHARMACEUTICALS PAIN MANAGEMENT
  • Table 12 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST, THROUGH 2012 ($ BILLIONS)
  • Figure 9 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST, 2005-2012 ($ BILLIONS)
    • MEDICAL DEVICES PAIN MANAGEMENT
  • Table 13 GLOBAL MEDICAL DEVICES PAIN-MANAGEMENT MARKET FORECAST, THROUGH 2012 ($ MILLIONS)
  • Figure 10 GLOBAL MEDICAL DEVICES PAIN-MANAGEMENT MARKET FORECAST, 2005-2012 ($ MILLIONS)
    • PHARMACEUTICALS PAIN-MANAGEMENT MARKET ANALYSIS
      • GLOBAL PHARMACEUTICAL PAIN-MANAGEMENT MARKET
  • Table 14 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST, THROUGH 2012 ($ BILLIONS)
  • Figure 11 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST, 2005-2012 ($ BILLIONS)
  • Table 15 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET BY TYPE, 2007 AND 2012 (%)
  • Figure 12 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET, 2007 (%)
  • Figure 13 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET, 2012 (%)
    • MARKET ANALYSIS BY APPLICATION
  • Table 16 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET FORECAST BY APPLICATION, THROUGH 2012 ($ BILLIONS)
  • Table 16 (CONTINUED)
  • Table 17 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES BY APPLICATION, 2007 AND 2012 (%)
  • Figure 14 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES BY APPLICATION, 2007 (%)
  • Figure 15 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES BY APPLICATION, 2012 (%)
    • GEOGRAPHIC MARKET ANALYSIS
  • Table 18 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET BY REGION, THROUGH 2012 ($ BILLIONS)
  • Figure 16 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET BY REGION, 2005-2012 ($ BILLIONS)
    • GEOGRAPHIC DISTRIBUTION
  • Table 19 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES, BY REGION, 2007 AND 2012 (%)
  • Figure 17 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES, BY REGION, 2007 (%)
  • Figure 18 GLOBAL PHARMACEUTICALS PAIN-MANAGEMENT MARKET SHARES, BY REGION, 2012 (%)
• Chapter 5 - MEDICAL IMAGING: EQUIPMENT AND RELATED PRODUCTS
  • MEDICAL IMAGING: EQUIPMENT AND RELATED PRODUCTS
  • INTRODUCTION
    • STUDY GOAL AND OBJECTIVES
    • SCOPE OF REPORT
    • METHODOLOGY AND INFORMATION SOURCES
    • ABOUT THE AUTHOR
    • RELATED BCC REPORTS
  • SUMMARY
  • Summary Table: U.S. MARKET PROJECTIONS FOR MEDICAL IMAGING EQUIPMENT BY SEGMENT, THROUGH 2012 ($ MILLIONS)
  • Summary Figure: U.S. MARKET PROJECTIONS FOR MEDICAL IMAGING EQUIPMENT BY SEGMENT, 2004-2012 ($ MILLIONS)
    • U.S. MARKET FOR MEDICAL IMAGING BY MODALITY/ SEGMENT
  • Table 12 U.S. MARKET PROJECTIONS FOR MEDICAL IMAGING BY SEGMENT, THROUGH 2012 ($ MILLIONS)
    • ULTRASOUND IMAGING EQUIPMENT
  • Table 13 U.S. MARKET PROJECTIONS FOR ULTRASOUND SCANNERS BY TYPE, THROUGH 2012 ($ MILLIONS)
  • Figure 5 U.S. MARKET PROJECTIONS FOR ULTRASOUND SCANNERS BY TYPE, 2004-2012 ($ MILLIONS)
  • Table 14 U.S. MARKET PROJECTIONS FOR ULTRASOUND SCANNERS BY TYPE, THROUGH 2012 ($ MILLIONS)
  • Figure 6 U.S. MARKET PROJECTIONS FOR ULTRASOUND SCANNERS BY TYPE, 2004-2012 ($ MILLIONS)
    • MRI SCANNERS
  • Table 15 U.S. MARKET PROJECTIONS FOR MRI IMAGING EQUIPMENT BY PRODUCT, THROUGH 2012 ($ MILLIONS)
  • Figure 7 U.S. MARKET PROJECTIONS FOR MRI IMAGING EQUIPMENT BY PRODUCT, 2004-2012 ($ MILLIONS)
    • MRI SCANNERS (CONTINUED)
    • U.S MARKET FOR RADIOGRAPHIC SCANNERS
  • Table 16 U.S. MARKET PROJECTIONS FOR RADIOGRAPHY IMAGING EQUIPMENT BY SUBSEGMENT, THROUGH 2012 ($ MILLIONS)
  • Figure 8 U.S. MARKET PROJECTIONS FOR RADIOGRAPHY IMAGING EQUIPMENT BY SUBSEGMENT, 2004-2012 ($ MILLIONS)
    • U.S MARKET FOR COMPUTED TOMOGRAPHY SCANNERS
  • Table 17 U.S. MARKET PROJECTIONS FOR CT SCANNERS BY PRODUCT TYPE, THROUGH 2012 ($ MILLIONS)
  • Figure 9 U.S. MARKET PROJECTIONS FOR CT SCANNERS BY PRODUCT TYPE, 2004-2012 ($ MILLIONS)
  • Figure 10 HIGHEST NUMBER OF DETECTORS REPORTED AT IMAGING FACILITIES IN THE U.S. (%)
  • Figure 10 (CONTINUED)
    • U.S. MARKET FOR PET SCANNERS
  • Table 18 U.S. MARKET PROJECTIONS FOR PET SCANNERS BY PRODUCT TYPE, THROUGH 2012 ($ MILLIONS)
  • Figure 11 U.S. MARKET PROJECTIONS FOR PET SCANNERS BY PRODUCT, 2004-2012 ($ MILLIONS)
• Chapter 6 - THE HOME MEDICAL EQUIPMENT MARKET
  • THE HOME MEDICAL EQUIPMENT MARKET
  • INTRODUCTION
    • STUDY BACKGROUND
    • STUDY GOALS AND OBJECTIVES
    • INTENDED AUDIENCE
    • SCOPE OF REPORT
    • INFORMATION SOURCES
    • ANALYST CREDENTIALS
    • RELATED BCC RESEARCH
  • EXECUTIVE SUMMARY
  • Summary Table: GLOBAL SALES OF HOME MEDICAL EQUIPMENT, THROUGH 2012 ($ BILLIONS)
  • Summary Figure: SALES OF HOME MEDICAL EQUIPMENT BY REGION, 2006-2012 (%)
  • OVERVIEW
    • GENERAL DESCRIPTION
      • DEFINITIONS
    • PRODUCT SEGMENTS
      • ASSISTIVE DEVICES
        • Wheelchairs and Scooters
        • Wheelchairs
        • Scooters
      • Home Care Beds
    • INFUSION PRODUCTS
      • Insulin Pumps
    • RESPIRATORY THERAPY PRODUCTS
      • Inhalers
        • Metered Dose Inhalers
        • Dry Powder Inhalers
      • Nebulizers
      • Oxygen Concentrators
      • Gaseous Oxygen System
      • Continuous Positive Airway Pressure (CPAP) Devices
      • Home Ventilators
      • Suction Machines
    • DIALYSIS EQUIPMENT
      • Hemodialysis
        • Dialysis Machine
      • Peritoneal Dialysis
        • CCPD Cycler
    • HOME DEFIBRILLATORS
    • MONITORS AND SENSORS
      • Blood Pressure Monitors
      • Aneroid Monitors
      • Digital Blood Pressure Monitors
      • Peak Flow Meters
      • Glucose Monitors
        • Glucose Monitors (Continued)
        • Glucose Monitors (Continued)
        • Glucose Monitors (Continued)
      • Apnea and SIDS Monitors
      • Cholesterol Monitors
      • Fetal Monitors
      • Home Cardiac Monitors
      • New Home Monitoring Technologies
      • Embedded Monitors
      • Wearable Monitors
        • Wearable Monitors (Continued)
  • HME MARKETS
    • SUMMARY
      • GLOBAL MARKET TRENDS
  • Table 11 GLOBAL HME SALES BY TYPE OF EQUIPMENT, THROUGH 2012 ($ MILLIONS)
  • Figure 16 TRENDS IN THE GLOBAL HME MARKET, 2006-2012 ($ BILLIONS)
    • MARKET BY HME SEGMENT
  • Figure 17 HME MARKET BY TYPE OF HME, 2006 AND 2012 (%)
    • MARKET BY DISEASE/CONDITION TREATED
  • Figure 18 HME MARKET BY TYPE OF DISEASE/CONDITION TREATED, 2006 AND 2012
  • Figure 18 (CONTINUED)
  • Table 12 HME MARKET BY TYPE OF DISEASE/CONDITION TREATED, THROUGH 2012 ($ MILLIONS)
    • MARKET BY GEOGRAPHICAL SEGMENT
  • Figure 19 HME MARKET BY TYPE OF REGION, 2006 AND 2012 (%)
  • Figure 19 (CONTINUED)
  • Table 13 MAJOR GEOGRAPHICAL MARKETS FOR HME, THROUGH 2012
  • Table 13 (CONTINUED)